<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font23 { font-size : 23; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font26">and </span>
   <span class="font23">influenza </span>
   <span class="font18">with </span>
   <span class="font17">resistance </span>
   <span class="font16">virus </span>
   <span class="font15">viruses </span>
   <span class="font15">for </span>
   <span class="font14">A/HN </span>
   <span class="font14">neuraminidase </span>
   <span class="font13">[]. </span>
   <span class="font13">resistant </span>
   <span class="font13">patients </span>
   <span class="font12">are </span>
   <span class="font12">Infect </span>
   <span class="font12">al. </span>
   <span class="font12">inhibitors </span>
   <span class="font12">oseltamivir </span>
   <span class="font12">that </span>
   <span class="font12">during </span>
   <span class="font12">been </span>
   <span class="font12">have </span>
   <span class="font12">inhibitor </span>
   <span class="font12">mutations </span>
   <span class="font12">from </span>
   <span class="font12">antiviral </span>
   <span class="font11">was </span>
   <span class="font11">emergence </span>
   <span class="font11">has </span>
   <span class="font11">treatment </span>
   <span class="font11">clinical </span>
   <span class="font11">variants </span>
   <span class="font11">HisTyr </span>
   <span class="font11">were </span>
   <span class="font11">The </span>
   <span class="font11">pandemic </span>
   <span class="font11">zanamivir </span>
   <span class="font11">oseltamivir-resistant </span>
   <span class="font11">human </span>
   <span class="font11">susceptibility </span>
   <span class="font11">may </span>
   <span class="font11">not </span>
   <span class="font11">acid </span>
   <span class="font11">isolates </span>
   <span class="font11">therapy </span>
   <span class="font11">drug </span>
   <span class="font11">immunocompromised </span>
   <span class="font11">{background </span>
   <span class="font11">(HN) </span>
   <span class="font11">studies </span>
   <span class="font11">children </span>
   <span class="font11">mutation </span>
   <span class="font11">amino </span>
   <span class="font11">infected </span>
   <span class="font11">avian </span>
   <span class="font11">found </span>
   <span class="font11">Agents </span>
   <span class="font10">[–]. </span>
   <span class="font10">against </span>
   <span class="font10">margin </span>
   <span class="font10">reduced </span>
   <span class="font10">rimantadine </span>
   <span class="font10">this </span>
   <span class="font10">viral </span>
   <span class="font10">A(HN) </span>
   <span class="font10">Dis./ </span>
   <span class="font10">change </span>
   <span class="font10">more </span>
   <span class="font10">most </span>
   <span class="font10">study </span>
   <span class="font10">treated </span>
   <span class="font10">vitro </span>
   <span class="font10">{border-style </span>
   <span class="font10">after </span>
   <span class="font10">detected </span>
   <span class="font10">highly </span>
   <span class="font10">px;} </span>
   <span class="font10">seasonal </span>
   <span class="font10">these </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">also </span>
   <span class="font10">amantadine </span>
   <span class="font10">frequency </span>
   <span class="font10">gene </span>
   <span class="font10">novel </span>
   <span class="font10">use </span>
   <span class="font10">Resistance </span>
   <span class="font10">cell </span>
   <span class="font10">circulating </span>
   <span class="font10">fitness </span>
   <span class="font10">replication </span>
   <span class="font10">Engl </span>
   <span class="font10">United </span>
   <span class="font10">among </span>
   <span class="font10">assays </span>
   <span class="font10">inhibitor-resistant </span>
   <span class="font10">shedding </span>
   <span class="font10">viruses, </span>
   <span class="font10">which </span>
   <span class="font10">A/HN, </span>
   <span class="font10">compared </span>
   <span class="font10">due </span>
   <span class="font10">transmission </span>
   <span class="font10">This </span>
   <span class="font10">[], </span>
   <span class="font10">but </span>
   <span class="font10">combination </span>
   <span class="font10">detection </span>
   <span class="font10">drug-resistant </span>
   <span class="font10">illness </span>
   <span class="font10">isolated </span>
   <span class="font10">than </span>
   <span class="font10">ArgLys </span>
   <span class="font10">Chemother./AAC.- </span>
   <span class="font10">SerAsn </span>
   <span class="font10">changes </span>
   <span class="font10">currently </span>
   <span class="font10">demonstrated </span>
   <span class="font10">development </span>
   <span class="font10">had </span>
   <span class="font10">infection </span>
   <span class="font10">its </span>
   <span class="font10">strains </span>
   <span class="font10">such </span>
   <span class="font10">susceptible </span>
   <span class="font10">transmissibility </span>
   <span class="font10">Influenza </span>
   <span class="font10">NAI, </span>
   <span class="font10">Res./j.antiviral... </span>
   <span class="font10">active </span>
   <span class="font10">activity </span>
   <span class="font10">between </span>
   <span class="font10">both </span>
   <span class="font10">days </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">one </span>
   <span class="font10">peramivir </span>
   <span class="font10">reported </span>
   <span class="font10">season </span>
   <span class="font10">using </span>
   <span class="font10">wild-type </span>
   <span class="font10">These </span>
   <span class="font10">adults </span>
   <span class="font10">analysis </span>
   <span class="font10">associated </span>
   <span class="font10">available </span>
   <span class="font10">can </span>
   <span class="font10">conferring </span>
   <span class="font10">course </span>
   <span class="font10">high </span>
   <span class="font10">over </span>
   <span class="font10">pathogenic </span>
   <span class="font10">recent </span>
   <span class="font10">two </span>
   <span class="font10">type </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">Japan </span>
   <span class="font10">Pathoge./journal.ppat. </span>
   <span class="font10">all </span>
   <span class="font10">amantadine-resistant </span>
   <span class="font10">different </span>
   <span class="font10">drugs </span>
   <span class="font10">effective </span>
   <span class="font10">hospitalized </span>
   <span class="font10">including </span>
   <span class="font10">inhibitory </span>
   <span class="font10">phenotypic </span>
   <span class="font10">prevention </span>
   <span class="font10">receptor </span>
   <span class="font10">result </span>
   <span class="font10">ribavirin </span>
   <span class="font10">sensitivity </span>
   <span class="font10">some </span>
   <span class="font10">variant </span>
   <span class="font10">vivo </span>
   <span class="font10">when </span>
   <span class="font10">who </span>
   <span class="font10">.). </span>
   <span class="font10">A/N </span>
   <span class="font10">Amantadine </span>
   <span class="font10">GluVal </span>
   <span class="font10">No. </span>
   <span class="font10">States </span>
   <span class="font10">agents </span>
   <span class="font10">animal </span>
   <span class="font10">antivirals </span>
   <span class="font10">binding </span>
   <span class="font10">cases </span>
   <span class="font10">der </span>
   <span class="font10">documented </span>
   <span class="font10">higher </span>
   <span class="font10">increased </span>
   <span class="font10">infections </span>
   <span class="font10">nursing </span>
   <span class="font10">oseltamivir, </span>
   <span class="font10">patients, </span>
   <span class="font10">presence </span>
   <span class="font10">px; </span>
   <span class="font10">several </span>
   <span class="font10">should </span>
   <span class="font10">their </span>
   <span class="font10">virus, </span>
   <span class="font10">while </span>
   <span class="font10">{font-family </span>
   <span class="font10">.van </span>
   <span class="font10">Although </span>
   <span class="font10">Children—outpatient </span>
   <span class="font10">Clinical </span>
   <span class="font10">Resistant </span>
   <span class="font10">Since </span>
   <span class="font10">Study </span>
   <span class="font10">Table </span>
   <span class="font10">Virol./JVI.- </span>
   <span class="font10">about </span>
   <span class="font10">absence </span>
   <span class="font10">al.A </span>
   <span class="font10">al.Antiviral </span>
   <span class="font10">al.The </span>
   <span class="font10">amantadine, </span>
   <span class="font10">clade </span>
   <span class="font10">class </span>
   <span class="font10">clinically </span>
   <span class="font10">common </span>
   <span class="font10">community </span>
   <span class="font10">countries </span>
   <span class="font10">data </span>
   <span class="font10">emerge </span>
   <span class="font10">font-size </span>
   <span class="font10">global </span>
   <span class="font10">likely </span>
   <span class="font10">loss </span>
   <span class="font10">prolonged </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">rapid </span>
   <span class="font10">severe </span>
   <span class="font10">shed </span>
   <span class="font10">subtype </span>
   <span class="font10">surveillance </span>
   <span class="font10">usually </span>
   <span class="font10">virulence </span>
   <span class="font10">viruses. </span>
   <span class="font10">young </span>
   <span class="font10">(%) </span>
   <span class="font10">(Table </span>
   <span class="font10">.HurtACet </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Chemother./AAC...-. </span>
   <span class="font10">Clin </span>
   <span class="font10">Most </span>
   <span class="font10">Other </span>
   <span class="font10">Rimantadine </span>
   <span class="font10">There </span>
   <span class="font10">VriesEet </span>
   <span class="font10">Worldwide </span>
   <span class="font10">Zanamivir </span>
   <span class="font10">al.Emergence </span>
   <span class="font10">al.Influenza </span>
   <span class="font10">birds </span>
   <span class="font10">child </span>
   <span class="font10">cross-resistance </span>
   <span class="font10">culture </span>
   <span class="font10">day </span>
   <span class="font10">developing </span>
   <span class="font10">differences </span>
   <span class="font10">double; </span>
   <span class="font10">duration </span>
   <span class="font10">effectiveness </span>
   <span class="font10">efficacy </span>
   <span class="font10">identified </span>
   <span class="font10">low </span>
   <span class="font10">models </span>
   <span class="font10">need </span>
   <span class="font10">observed </span>
   <span class="font10">only </span>
   <span class="font10">pathogenicity </span>
   <span class="font10">patterns </span>
   <span class="font10">polymerase </span>
   <span class="font10">receiving </span>
   <span class="font10">recovery </span>
   <span class="font10">resistance, </span>
   <span class="font10">resistance. </span>
   <span class="font10">respiratory </span>
   <span class="font10">role </span>
   <span class="font10">secondary </span>
   <span class="font10">significant </span>
   <span class="font10">single </span>
   <span class="font10">spread </span>
   <span class="font10">there </span>
   <span class="font10">well </span>
   <span class="font10">wild </span>
   <span class="font10">would </span>
   <span class="font10">(&amp;lt;. </span>
   <span class="font10">(A/HN, </span>
   <span class="font10">A(HN)pdm </span>
   <span class="font10">Adults </span>
   <span class="font10">Children </span>
   <span class="font10">Dis </span>
   <span class="font10">Dis./eid. </span>
   <span class="font10">Drug </span>
   <span class="font10">Given </span>
   <span class="font10">Hayden </span>
   <span class="font10">Microbiol./JCM...-. </span>
   <span class="font10">NAI-CL, </span>
   <span class="font10">NAI-FA, </span>
   <span class="font10">Oseltamivir </span>
   <span class="font10">PCR </span>
   <span class="font10">Res./S-()- </span>
   <span class="font10">South </span>
   <span class="font10">University </span>
   <span class="font10">acute </span>
   <span class="font10">al.Clinical </span>
   <span class="font10">al.Neuraminidase </span>
   <span class="font10">al.Oseltamivir-resistant </span>
   <span class="font10">alone </span>
   <span class="font10">animals </span>
   <span class="font10">antibodies </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">carrying </span>
   <span class="font10">cause </span>
   <span class="font10">channel </span>
   <span class="font10">combinations </span>
   <span class="font10">confers </span>
   <span class="font10">could </span>
   <span class="font10">described </span>
   <span class="font10">early </span>
   <span class="font10">effect </span>
   <span class="font10">enzyme </span>
   <span class="font10">experimentally </span>
   <span class="font10">exposed </span>
   <span class="font10">ferretsPLoS </span>
   <span class="font10">four </span>
   <span class="font10">group </span>
   <span class="font10">hemagglutinin </span>
   <span class="font10">ill </span>
   <span class="font10">increase </span>
   <span class="font10">influenza, </span>
   <span class="font10">influenza: </span>
   <span class="font10">intravenous </span>
   <span class="font10">ion </span>
   <span class="font10">isolation </span>
   <span class="font10">laninamivir </span>
   <span class="font10">limited </span>
   <span class="font10">longer </span>
   <span class="font10">many </span>
   <span class="font10">mice </span>
   <span class="font10">multidrug-resistant </span>
   <span class="font10">mutant </span>
   <span class="font10">nasal </span>
   <span class="font10">noted </span>
   <span class="font10">ongoing </span>
   <span class="font10">oseltamivir-treated </span>
   <span class="font10">outbreaks </span>
   <span class="font10">particularly </span>
   <span class="font10">passage </span>
   <span class="font10">permissive </span>
   <span class="font10">postexposure </span>
   <span class="font10">primary </span>
   <span class="font10">protein </span>
   <span class="font10">rapidly </span>
   <span class="font10">reduction </span>
   <span class="font10">result, </span>
   <span class="font10">selected </span>
   <span class="font10">sequence </span>
   <span class="font10">solid; </span>
   <span class="font10">studied </span>
   <span class="font10">substitution </span>
   <span class="font10">subtypes </span>
   <span class="font10">tested </span>
   <span class="font10">those </span>
   <span class="font10">three </span>
   <span class="font10">types </span>
   <span class="font10">under </span>
   <span class="font10">used </span>
   <span class="font10">utilized </span>
   <span class="font10">where </span>
   <span class="font10">years) </span>
   <span class="font10">zanamivir, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%) </span>
   <span class="font10">-fold </span>
   <span class="font10">.HaydenFGet </span>
   <span class="font10">Control </span>
   <span class="font10">Dis./infdis/.. </span>
   <span class="font10">For </span>
   <span class="font10">Further, </span>
   <span class="font10">GluVal, </span>
   <span class="font10">HN, </span>
   <span class="font10">His </span>
   <span class="font10">Hong </span>
   <span class="font10">Immunocompromised </span>
   <span class="font10">Information </span>
   <span class="font10">Japan, </span>
   <span class="font10">MDCK </span>
   <span class="font10">Med </span>
   <span class="font10">Med. </span>
   <span class="font10">Med./NEJMoa </span>
   <span class="font10">Medicine, </span>
   <span class="font10">Mutations </span>
   <span class="font10">RNA </span>
   <span class="font10">Recently, </span>
   <span class="font10">Studies </span>
   <span class="font10">Such </span>
   <span class="font10">Tyr </span>
   <span class="font10">Yes </span>
   <span class="font10">ability </span>
   <span class="font10">adult </span>
   <span class="font10">al.Characterization </span>
   <span class="font10">al.Effect </span>
   <span class="font10">al.Global </span>
   <span class="font10">al.Oseltamivir </span>
   <span class="font10">antibody </span>
   <span class="font10">any </span>
   <span class="font10">apparent </span>
   <span class="font10">approval </span>
   <span class="font10">approved </span>
   <span class="font10">attenuated </span>
   <span class="font10">basis </span>
   <span class="font10">because </span>
   <span class="font10">benefit </span>
   <span class="font10">bold </span>
   <span class="font10">case </span>
   <span class="font10">caused </span>
   <span class="font10">cells </span>
   <span class="font10">chain </span>
   <span class="font10">challenges </span>
   <span class="font10">classes </span>
   <span class="font10">clones </span>
   <span class="font10">commonly </span>
   <span class="font10">confer </span>
   <span class="font10">conserved </span>
   <span class="font10">courier; </span>
   <span class="font10">determine </span>
   <span class="font10">did </span>
   <span class="font10">drug, </span>
   <span class="font10">either </span>
   <span class="font10">em; </span>
   <span class="font10">exposure </span>
   <span class="font10">ferrets </span>
   <span class="font10">ferretsJ </span>
   <span class="font10">field </span>
   <span class="font10">first </span>
   <span class="font10">following </span>
   <span class="font10">functional </span>
   <span class="font10">genotypic </span>
   <span class="font10">given </span>
   <span class="font10">hosts </span>
   <span class="font10">household </span>
   <span class="font10">humans </span>
   <span class="font10">importance </span>
   <span class="font10">incidence </span>
   <span class="font10">index </span>
   <span class="font10">influence </span>
   <span class="font10">influenza. </span>
   <span class="font10">inhibition </span>
   <span class="font10">initially </span>
   <span class="font10">isolate </span>
   <span class="font10">less </span>
   <span class="font10">low-pathogenic </span>
   <span class="font10">management </span>
   <span class="font10">mechanisms </span>
   <span class="font10">mutation, </span>
   <span class="font10">new </span>
   <span class="font10">nine </span>
   <span class="font10">outcomes </span>
   <span class="font10">outpatients </span>
   <span class="font10">patients. </span>
   <span class="font10">position </span>
   <span class="font10">positions </span>
   <span class="font10">possible </span>
   <span class="font10">potential </span>
   <span class="font10">predicted </span>
   <span class="font10">present </span>
   <span class="font10">primarily </span>
   <span class="font10">prior </span>
   <span class="font10">properties </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized </span>
   <span class="font10">recipients </span>
   <span class="font10">reduction, </span>
   <span class="font10">regions </span>
   <span class="font10">risk </span>
   <span class="font10">same </span>
   <span class="font10">selective </span>
   <span class="font10">showed </span>
   <span class="font10">sialic </span>
   <span class="font10">since </span>
   <span class="font10">stem </span>
   <span class="font10">suggests </span>
   <span class="font10">swine </span>
   <span class="font10">symptoms </span>
   <span class="font10">testing </span>
   <span class="font10">therapeutic </span>
   <span class="font10">titers </span>
   <span class="font10">transplant </span>
   <span class="font10">virusesJ </span>
   <span class="font10">without </span>
  </p>
 </body>
</html>
